Alliancebernstein L.P. Crinetics Pharmaceuticals, Inc. Transaction History

Alliancebernstein L.P.

  • $287 Billion
  • Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 92,530 shares of CRNX stock, worth $5.12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
92,530
Previous 92,530 -0.0%
Holding current value
$5.12 Million
Previous $4.14 Million 14.04%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$42.12 - $51.91 $1.06 Million - $1.31 Million
25,260 Added 37.55%
92,530 $4.14 Million
Q4 2023

Feb 14, 2024
BUY
$25.62 - $37.07 $157,050 - $227,239
6,130 Added 10.03%
67,270 $2.39 Million
Q3 2023

Nov 14, 2023
BUY
$15.97 - $30.59 $158,741 - $304,064
9,940 Added 19.41%
61,140 $1.82 Million
Q2 2022

Aug 15, 2022
BUY
$16.49 - $27.64 $356,183 - $597,024
21,600 Added 72.97%
51,200 $955,000
Q1 2022

May 13, 2022
BUY
$17.15 - $28.31 $1,714 - $2,831
100 Added 0.34%
29,600 $650,000
Q2 2021

Jul 30, 2021
BUY
$15.9 - $21.15 $42,930 - $57,104
2,700 Added 10.07%
29,500 $556,000
Q1 2021

May 06, 2021
SELL
$13.3 - $17.55 $14,630 - $19,305
-1,100 Reduced 3.94%
26,800 $410,000
Q4 2020

Feb 08, 2021
BUY
$12.08 - $17.46 $24,160 - $34,920
2,000 Added 7.72%
27,900 $394,000
Q2 2020

Aug 13, 2020
BUY
$13.04 - $23.23 $144,744 - $257,853
11,100 Added 75.0%
25,900 $454,000
Q1 2020

May 14, 2020
BUY
$11.52 - $26.46 $34,560 - $79,380
3,000 Added 25.42%
14,800 $218,000
Q4 2019

Feb 18, 2020
BUY
$15.24 - $25.09 $9,144 - $15,054
600 Added 5.36%
11,800 $296,000
Q3 2019

Nov 14, 2019
BUY
$14.91 - $25.01 $32,802 - $55,022
2,200 Added 24.44%
11,200 $168,000
Q2 2019

Aug 14, 2019
BUY
$21.48 - $27.71 $193,320 - $249,390
9,000 New
9,000 $225,000

Others Institutions Holding CRNX

# of Institutions
242
Shares Held
79.6M
Call Options Held
23.3K
Put Options Held
44.3K
View Full List

About Crinetics Pharmaceuticals, Inc.

CRNX Quotes by TradingView
  • Ticker CRNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,752,800
  • Market Cap $2.98B
  • Description
  • Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...
More about CRNX
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email